Metabolic reprogramming through mitochondrial dysfunctions impairs trastuzumab-emtansine (T-DM1) response

12/06/2019 14:00h.

Lugar: Sala Xipre, 173.06

Tipo evento: Sesiones científicas

Ponentes: Mohammad Ali Sabbaghi

Organizador: Cancer, IMIM

Volver